Cuff size affects accuracy of blood pressure measurements
Mar 02, 2022
Overestimation of blood pressure with use of a cuff that was too small misclassified 39% of participants as having hypertension.
Increase in blood pressure at night ups risk for death in diabetes patients
Sep 30, 2021
Relative to those with a dip in nighttime systolic blood pressure, nondippers and reverse dippers have higher a prevalence of cardiac autonomic neuropathy.
ASN: Chlorthalidone aids BP control in patients with CKD and HTN
Nov 12, 2021
For patients with stage 4 chronic kidney disease and poorly controlled hypertension, the addition of low dose of chlorthalidone improves blood pressure control.
Social isolation: A serious but under-recognized health risk
By
Cathy Lipton, MD
Jul 28, 2022
How senior living communities can build on pandemic lessons to reduce loneliness.
2002 to 2014 saw increase in hypertensive crisis hospitalizations
Feb 01, 2022
The increase in crisis hospitalizations was steady for men and women; a decrease was seen in the odds of death during these crises.
BP control lower for current smokers, especially men
Nov 15, 2021
Rates of BP control were lower for current smokers; 45.5% of men had blood pressure >180 and/or >100 mm Hg.
1990 to 2019 saw doubling of number of people with hypertension
Aug 25, 2021
The researchers found that despite a stable global age-standardized prevalence, from 1990 to 2019, the number of people aged 30 to 79 years with hypertension doubled from 331 and 317 million women and...
Links between potassium intake, BP and CVD events differ by sex
Jul 26, 2022
For women, an inverse slope between potassium intake and systolic blood pressure was steeper for those within the highest versus lowest tertile of sodium intake.
Greater variety of dietary protein may lower risk for hypertension
Mar 10, 2022
Protein consumed in moderate amounts from various sources was linked to a lower risk for developing hypertension.
Certain antihypertensive agents may aid cognition in elderly
Jun 21, 2021
Memory recall is better for up to three years with blood-brain barrier-crossing renin-angiotensin drugs versus nonpenetrant counterparts.